15 weeks to go - World Orphan Drug Congress USA 2016

15 weeks until the only global gathering for the rare disease industry

In Orphan Drug Congress, Orphan Drugs Live by Freya Smale

The rare disease industry’s only global gathering returns for its 6th year, bigger and better than ever. Terrapinn invites you to the World Orphan Drug Congress USA, a commercially-focused global meeting for biotechs, pharma developing orphan drugs together with rare disease patient groups, payers, and regulators.

Event details:

  • 2 days of conference content
  • A pre-conference workshop day on April 20th with 8 workshops and 2 full day seminars for you to choose from*
  • 800+ industry stakeholders all gathered under one roof
  • 150+ speakers- all industry leaders providing perspectives from around the world
  • 50+ sponsors offering solutions to suit your business needs

Download the brochure now to see the full agenda >

We are thrilled to announce our speaker line-up, which includes industry leaders from across Academic Medical Centers/ Hospitals, Industry, Government Institutions, Patient (Advocacy Groups), Regulators, Solution Providers/Experts, Payers and Associations.

Our 2016 speaking faculty includes:

  • Emil Kakkis, President & CEO, Ultragenyx 
  • Richard Moscicki, Deputy Center Director for Science Operations, Center for Drug Evaluation and Research, FDA 
  • Art Caplan, Head, Division of Medical Ethics, NYU Langone Medical Center 
  • Steven Ryder, Senior Vice President and Chief Development Officer, Alexion 
  • Bruno Sepodes, Chair, Committee for Orphan Medicinal Products (COMP), European Medicines Agency (EMA) 
  • Mark Baglin, Vice President, Product Strategy Team Leader, Angioedema Franchise, Rare Disease Business Unit, Shire 
  • Edmund Pezalla, Vice President, National Medical Director, Pharmacy Policy and Strategy, Aetna
  • Charles O’Neill, VP, Pharmacological Sciences, BioMarin Pharmaceutical
  • Rashmi Gopal-Srivastava, Director, Extramural Research Program, Office of Rare Diseases Research, NCATS, National Institutes of Health
  • Yann Le Cam, Chief Executive Officer, EURORDIS 
  • Peter Saltonstall, President & CEO, NORD 

For more information about their sessions and more, please download the event brochure here >

To book simply visit the website at: www.terrapinn.com/orphandrug

Keep up with all the latest WODC USA on #WODC or follow us at @OrphanConf